Febrile Infants - Diagnostic Assessment and Outcome
FIDO
1 other identifier
observational
555
2 countries
6
Brief Summary
The purpose of this study is to assess how clinicians apply guidance in the assessment of febrile infants presenting the the Emergency Department. The measurable outcomes are: Primary Objective Report the rates of serious and invasive bacterial infections in febrile infants Secondary Objectives Report on the predictive value of different clinical features for predicting bacterial infections. Report on the value of biomarkers for predicting serious and invasive bacterial infections. Assess the performance of clinical practice guidelines for the assessment of febrile infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2019
CompletedFirst Posted
Study publicly available on registry
December 12, 2019
CompletedStudy Start
First participant enrolled
March 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedMay 11, 2021
May 1, 2021
1 year
December 10, 2019
May 8, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Invasive bacterial infection
Invasive Bacterial Infection (non-contaminant) confirmed by culture or molecular diagnostic testing of a sterile site i.e. blood or cerebrospinal fluid (CSF). Staphylococcus epidermidis, Propionibacterium acnes, Streptococcus viridans, or Diphtheroides were considered contaminants.
seven days
Serious bacterial infections
Urinary tract infections defined as growth of ≥100 000 cfu/mL
seven days
Study Arms (1)
Group 1
All infants aged 0-90 days (inclusive) undergoing routine assessments for fever without source.
Eligibility Criteria
Infants aged 0-90 days (inclusive) with a fever of 38 degrees centigrade or higher recorded in the Emergency Department between the 31/08/2018 and the 01/09/2019.
You may qualify if:
- Any infant aged 0 to 90 days (inclusive) with a fever of 38 degrees centigrade or higher recorded in the Emergency Department.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Belfast Health and Social Care Trustlead
- Bristol Royal Hospital for Childrencollaborator
- University Hospitals, Leicestercollaborator
- Barts & The London NHS Trustcollaborator
- Children's Health Irelandcollaborator
- Royal Hospital for Children Glasgowcollaborator
- Royal Belfast Hospital for Sick Childrencollaborator
Study Sites (6)
Children's Health Ireland
Dublin, Ireland
Royal Belfast Hospital for Sick Children
Belfast, Northern Ireland, BT126BE, United Kingdom
Bristol Royal Children's Hospital
Bristol, United Kingdom
Royal Hospital for Children Glasgow
Glasgow, United Kingdom
Leicester Royal Infirmary
Leicester, United Kingdom
Royal London Hospital
London, United Kingdom
Related Publications (2)
Waterfield T, Foster S, Platt R, Barrett MJ, Durnin S, Maney JA, Roland D, McFetridge L, Mitchell H, Umana E, Lyttle MD; Paediatric Emergency Research in the UK and Ireland (PERUKI). Diagnostic test accuracy of dipstick urinalysis for diagnosing urinary tract infection in febrile infants attending the emergency department. Arch Dis Child. 2022 Dec;107(12):1095-1099. doi: 10.1136/archdischild-2022-324300. Epub 2022 Aug 24.
PMID: 36002228DERIVEDWaterfield T, Lyttle MD, Munday C, Foster S, McNulty M, Platt R, Barrett M, Rogers E, Durnin S, Jameel N, Maney JA, McGinn C, McFetridge L, Mitchell H, Puthucode D, Roland D; Paediatric Emergency Research in the UK and Ireland (PERUKI). Validating clinical practice guidelines for the management of febrile infants presenting to the emergency department in the UK and Ireland. Arch Dis Child. 2022 Apr;107(4):329-334. doi: 10.1136/archdischild-2021-322586. Epub 2021 Sep 16.
PMID: 34531196DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
December 10, 2019
First Posted
December 12, 2019
Study Start
March 1, 2020
Primary Completion
March 1, 2021
Study Completion
May 1, 2021
Last Updated
May 11, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will share
Anonymised datasets not containing any personal data will be available after publication